APO RESEARCH · REPORT
Orally Disintegrating Tablet Excipient
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications.An excipient is a pharmacologically inert adhesive substance used to bind the contents of a pill or tablet. This type of tablet separates in the mouth in contact with saliva, making it easy for a person to swallow the tablet without drinking water.
Product & engineering
Understand the product.
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications.An excipient is a pharmacologically inert adhesive substance used to bind the contents of a pill or tablet. This type of tablet separates in the mouth in contact with saliva, making it easy for a person to swallow the tablet without drinking water.
Selected research
Industry Research
Orally Disintegrating Tablet Excipient Industry Research Report 2026
Market perspective
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications.An excipient is a pharmacologically inert adhesive substance used to bind the contents of a pill or tablet. This type of tablet separates in the mouth in contact with saliva, making it easy for a person to swallow the tablet without drinking water.
McePharma (Vivesa holding) was the global greatest company in Orally Disintegrating Tablet Excipient industry, with the revenue market Share of 3% , followed by BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin-Etsu, Fuji Chemical Industries, Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical.APAC is the largest Orally Disintegrating Tablet Excipient market with about 30% market share. Americas is follower, accounting for about 27% market share.
Report Scope
Read the full market overview
This report quantifies the global Orally Disintegrating Tablet Excipient market in terms of revenue (US$ million) and, where applicable, sales volume (K MT), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K MT) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Orally Disintegrating Tablet Excipient Market by Company
BASF
JRS Pharma
Roquette
ABF Ingredients
DFE Pharma
Evonik
Merck KGaA
Ashland
Meggle Pharma
Shin-Etsu
Fuji Chemical Industries
McePharma (Vivesa holding)
Cargill Incorporated
Daicel Corporation
Anhui Sunhere Pharmaceutical
Orally Disintegrating Tablet Excipient Segment by Type
Binders
Glidents
Diluents
Disintegrants
Others
Orally Disintegrating Tablet Excipient Segment by Application
Anti-Psychotics Drug
Anti-Epileptics Drug
Others
Orally Disintegrating Tablet Excipient Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Orally Disintegrating Tablet Excipient market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Orally Disintegrating Tablet Excipient and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Orally Disintegrating Tablet Excipient.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Orally Disintegrating Tablet Excipient manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Orally Disintegrating Tablet Excipient by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Orally Disintegrating Tablet Excipient in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Binders
- Glidents
- Diluents
- Disintegrants
- Others
Applications
- Anti-Psychotics Drug
- Anti-Epileptics Drug
- Others
Companies covered
- BASF
- JRS Pharma
- Roquette
- ABF Ingredients
- DFE Pharma
- Evonik
- Merck KGaA
- Ashland
- Meggle Pharma
- Shin-Etsu
- Fuji Chemical Industries
- McePharma (Vivesa holding)
- Cargill Incorporated
- Daicel Corporation
- Anhui Sunhere Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Orally Disintegrating Tablet Excipient Market Size (2021-2032)
- 2.2.2 Global Orally Disintegrating Tablet Excipient Sales (2021-2032)
- 2.2.3 Global Orally Disintegrating Tablet Excipient Market Average Price (2021-2032)
- 2.3 Orally Disintegrating Tablet Excipient by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Binders
- 2.3.3 Glidents
- 2.3.4 Diluents
- 2.3.5 Disintegrants
- 2.3.6 Others
- 2.4 Orally Disintegrating Tablet Excipient by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Anti-Psychotics Drug
- 2.4.3 Anti-Epileptics Drug
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Orally Disintegrating Tablet Excipient Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Orally Disintegrating Tablet Excipient Sales (K MT) of Manufacturers (2021-2026)
- 3.3 Global Orally Disintegrating Tablet Excipient Revenue of Manufacturers (2021-2026)
- 3.4 Global Orally Disintegrating Tablet Excipient Average Price by Manufacturers (2021-2026)
- 3.5 Global Orally Disintegrating Tablet Excipient Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Orally Disintegrating Tablet Excipient, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Orally Disintegrating Tablet Excipient, Product Type & Application
- 3.8 Global Manufacturers of Orally Disintegrating Tablet Excipient, Established Date
- 3.9 Global Orally Disintegrating Tablet Excipient Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 BASF
- 4.1.1 BASF Company Information
- 4.1.2 BASF Business Overview
- 4.1.3 BASF Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 BASF Orally Disintegrating Tablet Excipient Product Portfolio
- 4.1.5 BASF Recent Developments
- 4.2 JRS Pharma
- 4.2.1 JRS Pharma Company Information
- 4.2.2 JRS Pharma Business Overview
- 4.2.3 JRS Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 JRS Pharma Orally Disintegrating Tablet Excipient Product Portfolio
- 4.2.5 JRS Pharma Recent Developments
- 4.3 Roquette
- 4.3.1 Roquette Company Information
- 4.3.2 Roquette Business Overview
- 4.3.3 Roquette Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Roquette Orally Disintegrating Tablet Excipient Product Portfolio
- 4.3.5 Roquette Recent Developments
- 4.4 ABF Ingredients
- 4.4.1 ABF Ingredients Company Information
- 4.4.2 ABF Ingredients Business Overview
- 4.4.3 ABF Ingredients Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 ABF Ingredients Orally Disintegrating Tablet Excipient Product Portfolio
- 4.4.5 ABF Ingredients Recent Developments
- 4.5 DFE Pharma
- 4.5.1 DFE Pharma Company Information
- 4.5.2 DFE Pharma Business Overview
- 4.5.3 DFE Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 DFE Pharma Orally Disintegrating Tablet Excipient Product Portfolio
- 4.5.5 DFE Pharma Recent Developments
- 4.6 Evonik
- 4.6.1 Evonik Company Information
- 4.6.2 Evonik Business Overview
- 4.6.3 Evonik Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Evonik Orally Disintegrating Tablet Excipient Product Portfolio
- 4.6.5 Evonik Recent Developments
- 4.7 Merck KGaA
- 4.7.1 Merck KGaA Company Information
- 4.7.2 Merck KGaA Business Overview
- 4.7.3 Merck KGaA Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Merck KGaA Orally Disintegrating Tablet Excipient Product Portfolio
- 4.7.5 Merck KGaA Recent Developments
- 4.8 Ashland
- 4.8.1 Ashland Company Information
- 4.8.2 Ashland Business Overview
- 4.8.3 Ashland Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Ashland Orally Disintegrating Tablet Excipient Product Portfolio
- 4.8.5 Ashland Recent Developments
- 4.9 Meggle Pharma
- 4.9.1 Meggle Pharma Company Information
- 4.9.2 Meggle Pharma Business Overview
- 4.9.3 Meggle Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Meggle Pharma Orally Disintegrating Tablet Excipient Product Portfolio
- 4.9.5 Meggle Pharma Recent Developments
- 4.10 Shin-Etsu
- 4.10.1 Shin-Etsu Company Information
- 4.10.2 Shin-Etsu Business Overview
- 4.10.3 Shin-Etsu Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Shin-Etsu Orally Disintegrating Tablet Excipient Product Portfolio
- 4.10.5 Shin-Etsu Recent Developments
- 4.11 Fuji Chemical Industries
- 4.11.1 Fuji Chemical Industries Company Information
- 4.11.2 Fuji Chemical Industries Business Overview
- 4.11.3 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Product Portfolio
- 4.11.5 Fuji Chemical Industries Recent Developments
- 4.12 McePharma (Vivesa holding)
- 4.12.1 McePharma (Vivesa holding) Company Information
- 4.12.2 McePharma (Vivesa holding) Business Overview
- 4.12.3 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Product Portfolio
- 4.12.5 McePharma (Vivesa holding) Recent Developments
- 4.13 Cargill Incorporated
- 4.13.1 Cargill Incorporated Company Information
- 4.13.2 Cargill Incorporated Business Overview
- 4.13.3 Cargill Incorporated Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Cargill Incorporated Orally Disintegrating Tablet Excipient Product Portfolio
- 4.13.5 Cargill Incorporated Recent Developments
- 4.14 Daicel Corporation
- 4.14.1 Daicel Corporation Company Information
- 4.14.2 Daicel Corporation Business Overview
- 4.14.3 Daicel Corporation Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Daicel Corporation Orally Disintegrating Tablet Excipient Product Portfolio
- 4.14.5 Daicel Corporation Recent Developments
- 4.15 Anhui Sunhere Pharmaceutical
- 4.15.1 Anhui Sunhere Pharmaceutical Company Information
- 4.15.2 Anhui Sunhere Pharmaceutical Business Overview
- 4.15.3 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Product Portfolio
- 4.15.5 Anhui Sunhere Pharmaceutical Recent Developments
5 Global Orally Disintegrating Tablet Excipient Market Scenario by Region
- 5.1 Global Orally Disintegrating Tablet Excipient Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Orally Disintegrating Tablet Excipient Sales by Region: 2021-2032
- 5.2.1 Global Orally Disintegrating Tablet Excipient Sales by Region: 2021-2026
- 5.2.2 Global Orally Disintegrating Tablet Excipient Sales by Region: 2027-2032
- 5.3 Global Orally Disintegrating Tablet Excipient Revenue by Region: 2021-2032
- 5.3.1 Global Orally Disintegrating Tablet Excipient Revenue by Region: 2021-2026
- 5.3.2 Global Orally Disintegrating Tablet Excipient Revenue by Region: 2027-2032
- 5.4 North America Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
- 5.4.1 North America Orally Disintegrating Tablet Excipient Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Orally Disintegrating Tablet Excipient Sales by Country (2021-2032)
- 5.4.3 North America Orally Disintegrating Tablet Excipient Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
- 5.5.1 Europe Orally Disintegrating Tablet Excipient Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Orally Disintegrating Tablet Excipient Sales by Country (2021-2032)
- 5.5.3 Europe Orally Disintegrating Tablet Excipient Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
- 5.6.1 Asia Pacific Orally Disintegrating Tablet Excipient Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Orally Disintegrating Tablet Excipient Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Orally Disintegrating Tablet Excipient Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
- 5.7.1 South America Orally Disintegrating Tablet Excipient Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Orally Disintegrating Tablet Excipient Sales by Country (2021-2032)
- 5.7.3 South America Orally Disintegrating Tablet Excipient Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Orally Disintegrating Tablet Excipient Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Orally Disintegrating Tablet Excipient Sales by Type (2021-2032)
- 6.1.1 Global Orally Disintegrating Tablet Excipient Sales by Type (2021-2032) & (K MT)
- 6.1.2 Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2021-2032)
- 6.2 Global Orally Disintegrating Tablet Excipient Revenue by Type (2021-2032)
- 6.2.1 Global Orally Disintegrating Tablet Excipient Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2021-2032)
- 6.3 Global Orally Disintegrating Tablet Excipient Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Orally Disintegrating Tablet Excipient Sales by Application (2021-2032)
- 7.1.1 Global Orally Disintegrating Tablet Excipient Sales by Application (2021-2032) & (K MT)
- 7.1.2 Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2021-2032)
- 7.2 Global Orally Disintegrating Tablet Excipient Revenue by Application (2021-2032)
- 7.2.1 Global Orally Disintegrating Tablet Excipient Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2021-2032)
- 7.3 Global Orally Disintegrating Tablet Excipient Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Orally Disintegrating Tablet Excipient Value Chain Analysis
- 8.1.1 Orally Disintegrating Tablet Excipient Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Orally Disintegrating Tablet Excipient Production Mode & Process
- 8.2 Orally Disintegrating Tablet Excipient Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Orally Disintegrating Tablet Excipient Distributors
- 8.2.3 Orally Disintegrating Tablet Excipient Customers
9 Global Orally Disintegrating Tablet Excipient Analyzing Market Dynamics
- 9.1 Orally Disintegrating Tablet Excipient Industry Trends
- 9.2 Orally Disintegrating Tablet Excipient Industry Drivers
- 9.3 Orally Disintegrating Tablet Excipient Industry Opportunities and Challenges
- 9.4 Orally Disintegrating Tablet Excipient Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst